Don't Ignore This Chart!

Blog Article Title Image

Why Novo Nordisk's Stock Price Recovery Makes It a Promising Buy

by Jayanthi Gopalakrishnan

Novo Nordisk (NVO) reported Q1 earnings on May 2. Even though it was a positive report, sales of its weight-loss drug Wegovy came in below expectations, causing the NVO stock price to fall lower... Read More 

Don't Ignore This Chart!

Blog Article Title Image

AMD at a Crossroads: Buy Now or Brace for More Losses?

by Karl Montevirgen

Advanced Micro Devices (AMD) slightly topped Wall Street's earnings and guidance expectations on Tuesday, but, instead of rallying, its stock tumbled 7%. AMD was at its 61... Read More